BIOLOGICS MARKET ANALYSIS

Biologics Market, By Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-based Biologics, Gene-based Biologics, and Others), By Drug Classification (Branded Drugs and Generic Drugs), By Route of Administration (Oral, Parenteral, and Other Routes), By Mode of Purchase (Prescription-Based Drugs and Over-The-Counter Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa).

Published In : Feb 2025
Code : CMI2663
Pages :210
Formats :
Excel and PDF
Industry : Pharmaceutical

Biologics Market Size and Trends

Global biologics market is estimated to be valued at USD 577.5 Mn in 2025 and is expected to reach USD 1,169.8 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2025 to 2032.

Biologics Market Key Factors

To learn more about this report, Request sample copy

This growth is primarily driven by the increasing demand for monoclonal antibodies and recombinant proteins, which are crucial in the treatment of chronic diseases such as cancer, diabetes, and cardiovascular diseases. As the prevalence of these diseases continues to rise globally, the need for advanced biologic therapies that offer more targeted and effective treatment options becomes even more critical. Additionally, significant investments by leading pharmaceutical and biotechnology companies in R&D, particularly in the development of biosimilars and personalized biologics, are driving the market expansion.